These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16498705)

  • 1. Free choice of health plan combined with risk-adjusted capitation payments: are switchers and new enrolees good risks?
    van Vliet RC
    Health Econ; 2006 Aug; 15(8):763-74. PubMed ID: 16498705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-adjusted capitation based on the Diagnostic Cost Group Model: an empirical evaluation with health survey information.
    Lamers LM
    Health Serv Res; 1999 Feb; 33(6):1727-44. PubMed ID: 10029506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of supplementary health insurance on switching behaviour: evidence from Swiss data.
    Dormont B; Geoffard PY; Lamiraud K
    Health Econ; 2009 Nov; 18(11):1339-56. PubMed ID: 19267356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Who switches sickness funds in Israel?
    Shmueli A; Bendelac J; Achdut L
    Health Econ Policy Law; 2007 Jul; 2(Pt 3):251-65. PubMed ID: 18634649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The high costs of death: should health plans get higher payments when members die?
    van Vliet RC; Lamers LM
    Med Care; 1998 Oct; 36(10):1451-60. PubMed ID: 9794339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of health care utilization by German sickness fund members--with application to risk adjustment.
    Breyer F; Heineck M; Lorenz N
    Health Econ; 2003 May; 12(5):367-76. PubMed ID: 12720254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Pharmacy-based Cost Group model: validating and adjusting the classification of medications for chronic conditions to the Dutch situation.
    Lamers LM; van Vliet RC
    Health Policy; 2004 Apr; 68(1):113-21. PubMed ID: 15033558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk selection in the German public health insurance system.
    Nuscheler R; Knaus T
    Health Econ; 2005 Dec; 14(12):1253-71. PubMed ID: 15942977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Notes on the planned German health fund model].
    Robra BP; Mayrhofer T
    Gesundheitswesen; 2006 Oct; 68(10):650-2. PubMed ID: 17099827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prior health expenditures and risk sharing with insurers competing on quality.
    Marchand M; Sato M; Schokkaert E
    Rand J Econ; 2003; 34(4):647-69. PubMed ID: 14992229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk-adjusted capitation payments: developing a diagnostic cost groups classification for the Dutch situation.
    Lamers LM
    Health Policy; 1998 Jul; 45(1):15-32. PubMed ID: 10183010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching sickness funds in Israel: adverse selection or risk selection? Some insights from the analysis of the relative costs of switchers.
    Shmueli A
    Health Policy; 2011 Oct; 102(2-3):247-54. PubMed ID: 21839536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choices in health care: the European experience.
    Thomson S; Dixon A
    J Health Serv Res Policy; 2006 Jul; 11(3):167-71. PubMed ID: 16824264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk adjustment and primary health care in Chile.
    Vargas V; Wasem J
    Croat Med J; 2006 Jun; 47(3):459-68. PubMed ID: 16758525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk-adjusted capitation payment systems for health insurance plans in a competitive market.
    Lamers LM; van Vliet RC; van de Ven WP
    Expert Rev Pharmacoecon Outcomes Res; 2003 Oct; 3(5):541-9. PubMed ID: 19807388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The implementation of managed behavioral healthcare in Colorado and the effects on older Medicaid beneficiaries.
    Kaskie B; Wallace N; Kang S; Bloom J
    J Ment Health Policy Econ; 2006 Mar; 9(1):15-24. PubMed ID: 16733268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacy costs groups: a risk-adjuster for capitation payments based on the use of prescribed drugs.
    Lamers LM
    Med Care; 1999 Aug; 37(8):824-30. PubMed ID: 10448725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Made in the USA: the import of American Consumer Assessment of Health Plan Surveys (CAHPS) into the Dutch social insurance system.
    Delnoij DM; ten Asbroek G; Arah OA; de Koning JS; Stam P; Poll A; Vriens B; Schmidt P; Klazinga NS
    Eur J Public Health; 2006 Dec; 16(6):652-9. PubMed ID: 16524940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk adjustment and risk selection in Europe: 6 years later.
    van de Ven WP; Beck K; Van de Voorde C; Wasem J; Zmora I
    Health Policy; 2007 Oct; 83(2-3):162-79. PubMed ID: 17270311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.